A clinical trial to study the effect of two drugs, chakramarda mool churna and amalaki churna in Excessive vaginal white discharge

A comparative study of Chakramarda mool churn and Amalaki churn in the management of Shwetapradara - nil

Status

Active, not recruiting

Phases

Phase 2Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2024/09/073882

Enrollment

Registered

2024-09-13

Start date

Unknown

Completion date

Unknown

Last updated

2024-09-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N768- Other specified inflammation of vagina and vulva

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: Per vaginal excessive continuous abnormal white discharge Married women age group from 20 to 50 years of any class and any religion having clinical feature of Swetapradara Discharge per vagina with or without itching, burning sensation, foul smell and low backache and lower abdominal pain

Exclusion criteria

Exclusion criteria: Pregnancy and lactating woman Uterine prolapse PID Cervical erosion STD like Gonorrhea HIV VDRL Vaginal bleeding Severely ill patients Genital malignancy Uncontrolled Diabetes RBS more then 180mg/dl Patient with any structural defect in the female genital tract The patient who is participated in another research study within the last 6 months

Design outcomes

Primary

Measure	Time frame
Excessive vaginal white discharge associated with itching and smellTimepoint: 21 days	—

Secondary

Measure	Time frame
Yoni daha, lower abdominal painTimepoint: 21 days	—

Countries

India

Contacts

Public ContactDr Jyotikaben Manubhai Bamania

Shree Swaminarayan ayurvedic college,Kalol

jamunadevichandramouli@gmail.com9535881003

Outcome results